Dole Neha S, Yee Cristal S, Mazur Courtney M, Acevedo Claire, Alliston Tamara
Department of Orthopaedic Surgery, University of California, San Francisco (UCSF), San Francisco, CA, USA.
University of California (UC) Berkeley-UCSF Graduate Program in Bioengineering, San Francisco, CA, USA.
J Bone Miner Res. 2020 Aug;35(8):1549-1561. doi: 10.1002/jbmr.4023. Epub 2020 May 13.
Bone fragility is the product of defects in bone mass and bone quality, both of which show sex-specific differences. Despite this, the cellular and molecular mechanisms underpinning the sexually dimorphic control of bone quality remain unclear, limiting our ability to effectively prevent fractures, especially in postmenopausal osteoporosis. Recently, using male mice, we found that systemic or osteocyte-intrinsic inhibition of TGFβ signaling, achieved using the 9.6-kb DMP1 promoter-driven Cre recombinase (TβRII mice), suppresses osteocyte perilacunar/canalicular remodeling (PLR) and compromises bone quality. Because systemic TGFβ inhibition more robustly increases bone mass in female than male mice, we postulated that sex-specific differences in bone quality could likewise result, in part, from dimorphic regulation of PLR by TGFβ. Moreover, because lactation induces PLR, we examined the effect of TGFβ inhibition on the female skeleton during lactation. In contrast to males, female mice that possess an osteocyte-intrinsic defect in TGFβ signaling were protected from TGFβ-dependent defects in PLR and bone quality. The expression of requisite PLR enzymes, the lacunocanalicular network (LCN), and the flexural strength of female TβRII bone was intact. With lactation, however, bone loss and induction in PLR and osteocytic parathyroid hormone type I receptor (PTHR1) expression, were suppressed in TβRII bone, relative to the control littermates. Indeed, differential control of PTHR1 expression, by TGFβ and other factors, may contribute to dimorphism in PLR regulation in male and female TβRII mice. These findings provide key insights into the sex-based differences in osteocyte PLR that underlie bone quality and highlight TGFβ signaling as a crucial regulator of lactation-induced PLR. © 2020 American Society for Bone and Mineral Research.
骨脆性是骨量和骨质量缺陷的产物,二者均表现出性别特异性差异。尽管如此,支撑骨质量性别二态性控制的细胞和分子机制仍不清楚,这限制了我们有效预防骨折的能力,尤其是在绝经后骨质疏松症中。最近,我们使用雄性小鼠发现,通过9.6 kb DMP1启动子驱动的Cre重组酶(TβRII小鼠)实现的TGFβ信号通路的全身或骨细胞内在抑制,会抑制骨细胞陷窝/小管周围重塑(PLR)并损害骨质量。由于全身TGFβ抑制在雌性小鼠中比雄性小鼠更有力地增加骨量,我们推测骨质量的性别特异性差异同样可能部分源于TGFβ对PLR的二态性调节。此外,由于哺乳会诱导PLR,我们研究了TGFβ抑制对哺乳期雌性骨骼的影响。与雄性不同,在TGFβ信号通路中存在骨细胞内在缺陷的雌性小鼠免受PLR和骨质量中TGFβ依赖性缺陷的影响。雌性TβRII骨中必需的PLR酶、腔管网络(LCN)的表达以及抗弯强度均完好无损。然而,在哺乳期,相对于对照同窝小鼠,TβRII骨中的骨丢失以及PLR和骨细胞甲状旁腺激素I型受体(PTHR1)表达的诱导受到抑制。实际上,TGFβ和其他因素对PTHR1表达的差异控制可能导致雄性和雌性TβRII小鼠在PLR调节上的二态性。这些发现为骨质量基础上的骨细胞PLR性别差异提供了关键见解,并突出了TGFβ信号通路作为哺乳期诱导PLR的关键调节因子。© 2020美国骨与矿物质研究学会。